Ballicules.com

Fluticasone

FLOVENT

What it isInhaled or intranasal glucocorticoid agonist; asthma control and allergic rhinitis.

Why this oneIts unusually high CYP3A4 dependence lets ritonavir turn a nominally local steroid into systemic Cushing syndrome.

What limits itRinse after inhalation to limit candidiasis and dysphonia; high exposure can suppress growth and the adrenal axis.

FDA-approved for

FDA label

FDA dosingPopulationStartTargetMax
Allergic rhinitisAdult2 sprays/nostril QD (200 mcg/day)1 spray/nostril QD (maintenance)2 sprays/nostril/day (200 mcg/day)
Allergic rhinitisAdolescents/children ≥4 y1 spray/nostril QD (100 mcg/day)1 spray/nostril QD2 sprays/nostril/day (200 mcg/day)

Renal Undefined

Hepatic Monitor for signs of increased drug exposure

Instructions

Cautions

Adverse reactions

Pregnancy Insufficient human data; animal studies show corticosteroid-characteristic teratogenicity and decreased fetal weight at maternally toxic doses.

Lactation No data on presence in human milk; low concentrations of other corticosteroids detected in human milk.

NO BOXED WARNINGS

Principal riskOral candidiasis; systemic effects with a strong CYP3A4 inhibitor

Cost, est. cash$200–$900/month

Generic entry2031 est.

Classes and tags

Clinical profile

Therapeutic safety burden0 / 4
Overdose danger0 / 4
Weight-gain liability0 / 4
Sedation liability0 / 4
QT / Torsades0 / 4
Direct muscarinic antagonism0 / 4
Embryofetal risk0 / 4

Legacy pregnancy categoryC

Defining liabilityLocal irritation, sensitization or administration-site injury; negligible systemic toxicity at usual use.

Mechanism of action: Fluticasone ballicule

Fluticasone ballicule: receptor binding, kinetics and half-life diagram

Open Fluticasone in the interactive console ↗

Memory aids: mascots and interaction avatars

Fluticasone FLOVENT mascot mnemonic cartoon
“Flo’s ventilated Flute case”
Fluticasone CYP3A4 substrate avatar
CYP3A4 substrate

Open Fluticasone in the interactive console ↗